name: Dextromethorphan and guaifenesin only product in oral dose form


name: Dextromethorphan and promethazine only product in oral dose form


name: Dextromethorphan only product in oromucosal dose form


name: Diethylstilbestrol only product in parenteral dose form


name: Difluprednate only product in ocular dose form


name: Dihydroergotamine only product in oromucosal dose form


name: Dihydroergotamine only product in parenteral dose form


name: Hydrocortisone and iodoquinol only product in cutaneous dose form


name: Diphenhydramine and zinc acetate only product in cutaneous dose form


name: Docosanol only product in cutaneous dose form


name: Donepezil only product in oromucosal dose form


name: Dornase alfa only product in pulmonary dose form


name: Drospirenone- and ethinyl estradiol- and levomefolic acid-containing product


name: Ecallantide only product in parenteral dose form


name: Efinaconazole only product in cutaneous dose form


name: Enfuvirtide only product in parenteral dose form


name: Epinephrine and etidocaine only product in parenteral dose form


name: Epinephrine and mepivacaine only product in parenteral dose form


name: Equine antithymocyte immunoglobulin-containing product


name: Ertapenem only product in parenteral dose form


name: Esterified estrogen and methyltestosterone only product in oral dose form


name: Estrone only product in parenteral dose form


name: Ethacrynic acid only product in parenteral dose form


name: Ethinyl estradiol and ferrous fumarate and norethindrone only product in oral dose form


name: Etidocaine only product in parenteral dose form


name: Famotidine only product in oromucosal dose form


name: Fenoterol and ipratropium only product in pulmonary dose form


name: Fluocinolone and hydroquinone and tretinoin only product in cutaneous dose form


name: Fluorescein stain and proparacaine only product in ocular dose form


name: Fluorometholone and tobramycin only product in ocular dose form


name: Fosfomycin only product in oral dose form


name: Gadoteric acid only product in parenteral dose form


name: Gelatin only product in parenteral dose form


name: Goserelin only product in parenteral dose form


name: Halobetasol only product in cutaneous dose form


name: Hetastarch only product in parenteral dose form


name: Human anti-D immunoglobulin-containing product


name: Human immunoglobulin G only product in parenteral dose form


name: Hydrocortisone and pramoxine only product in cutaneous dose form


name: Hydroxyamphetamine and tropicamide only product in ocular dose form


name: Imiquimod only product in cutaneous dose form


name: Indacaterol only product in pulmonary dose form


name: Albuterol and ipratropium only product in pulmonary dose form


name: Isophane insulin- and recombinant human regular insulin-containing product


name: Ixabepilone only product in parenteral dose form


name: Lamivudine and nevirapine and stavudine only product in oromucosal dose form


name: Lamotrigine only product in oromucosal dose form


name: Lansoprazole only product in oromucosal dose form


name: Levomethadyl only product in oral dose form


name: Levosimendan only product in parenteral dose form


name: Loratadine only product in oromucosal dose form


name: Loteprednol and tobramycin only product in ocular dose form


name: Polyethylene glycol 3350 only product in oral dose form


name: Mafenide only product in cutaneous dose form


name: Meclizine only product in oromucosal dose form


name: Antimonic acid only product in parenteral dose form


name: Iotroxic acid only product in parenteral dose form


name: Meptazinol only product in parenteral dose form


name: Mequinol and tretinoin only product in cutaneous dose form


name: Gentian violet only product in cutaneous dose form


name: Metoclopramide only product in oromucosal dose form


name: Miconazole only product in oromucosal dose form


name: Mucin and xylitol only product in oromucosal dose form


name: Mycophenolic acid only product in oral dose form


name: Naphazoline and pheniramine only product in ocular dose form


name: Nepafenac only product in ocular dose form


name: Niacin and simvastatin only product in oral dose form


name: Nystatin only product in oromucosal dose form


name: Olanzapine only product in oromucosal dose form


name: Oxybutynin only product in transdermal dose form


name: Palifermin only product in parenteral dose form


name: Pegaptanib only product in parenteral dose form


name: Phenylalanine ammonia-lyase only product in parenteral dose form


name: Pegvisomant only product in parenteral dose form


name: Pemetrexed only product in parenteral dose form


name: Pemirolast only product in ocular dose form


name: Pentastarch only product in parenteral dose form


name: Phenylbutyric acid only product in oral dose form


name: Physostigmine and pilocarpine only product in ocular dose form


name: Pituitary follicle stimulating hormone- and pituitary luteinizing hormone-containing product


name: Plerixafor only product in parenteral dose form


name: Potassium gluconate only product in oral dose form


name: Prednisolone only product in oromucosal dose form


name: Propamidine only product in ocular dose form


name: Proparacaine only product in ocular dose form


name: Rabbit anti-human T-lymphocyte globulin only product in parenteral dose form


name: Ranibizumab only product in parenteral dose form


name: Rilonacept only product in parenteral dose form


name: Rizatriptan only product in oromucosal dose form


name: Romidepsin only product in parenteral dose form


name: Sacrosidase only product in oral dose form


name: Salicylic acid and zinc oxide only product in cutaneous dose form


name: Salmon calcitonin only product in nasal dose form


name: Selegiline only product in oromucosal dose form


name: Siltuximab only product in parenteral dose form


name: Simvastatin only product in oromucosal dose form


name: Sodium benzoate and sodium phenylacetate only product in parenteral dose form


name: 4-hydroxybutyric acid only product in oral dose form


name: Streptozocin only product in parenteral dose form


name: Sucrose only product in ocular dose form


name: Sulfabenzamide and sulfacetamide and sulfathiazole only product in vaginal dose form


name: Tedizolid only product in parenteral dose form


name: Telavancin only product in parenteral dose form


name: Temoporfin only product in parenteral dose form


name: Temozolomide only product in parenteral dose form


name: Tenecteplase only product in parenteral dose form


name: Teniposide only product in parenteral dose form


name: Tramadol only product in oromucosal dose form


name: Treprostinil only product in pulmonary dose form


name: Tuberculin purified protein derivative only product in parenteral dose form


name: Urofollitropin only product in parenteral dose form


name: Urokinase only product in parenteral dose form


name: Vardenafil only product in oromucosal dose form


name: Vedolizumab only product in parenteral dose form


name: Velaglucerase alfa only product in parenteral dose form


name: Zoledronic acid only product in parenteral dose form


name: Zolmitriptan only product in oromucosal dose form


name: Zolpidem only product in oromucosal dose form


name: Dissection of lymph nodes of bilateral sides of central compartment of neck


name: Arteriovenous extracorporeal membrane oxygenation


name: Intraoperative fixation of head using head fixation device


name: Clostridium histolyticum collagenase only product


name: Clostridium histolyticum collagenase only product in parenteral dose form


name: Acetic acid only product in solution for irrigation


name: Aclarubicin only product in parenteral dose form


name: Albiglutide only product in parenteral dose form


name: Ammonium lactate and salicylic acid only product


name: Ammonium lactate and salicylic acid only product in cutaneous dose form


name: Amylase and endopeptidase and pancreatic lipase only product


name: Amylase and endopeptidase and pancreatic lipase only product in oral dose form


name: Amylase and endopeptidase and triacylglycerol lipase only product


name: Amylase and endopeptidase and triacylglycerol lipase only product in oral dose form


name: Belladonna alkaloid and opium only product


name: Belladonna alkaloid and opium only product in rectal dose form


name: Benzalkonium and polyethylene only product


name: Benzalkonium and polyethylene only product in cutaneous dose form


name: Bovine hyaluronidase only product in parenteral dose form


name: Brompheniramine and codeine and phenylpropanolamine only product


name: Brompheniramine and codeine and phenylpropanolamine only product in oral dose form


name: Brompheniramine and dextromethorphan and phenylpropanolamine only product


name: Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form


name: Brompheniramine and dextromethorphan and pseudoephedrine only product


name: Brompheniramine and dextromethorphan and pseudoephedrine only product in oral dose form


name: Calcium electrolyte and cholecalciferol only product


name: Calcium electrolyte and cholecalciferol only product in oral dose form


name: Cetyl dimethicone only product in cutaneous dose form


name: Chlorhexidine and sodium nitrite only product


name: Chlorhexidine and sodium nitrite only product in cutaneous dose form


name: Choline and glycerin only product in otic dose form


name: Citric acid and potassium citrate and sodium citrate only product


name: Citric acid and potassium citrate and sodium citrate only product in oral dose form


name: Coal tar and pine tar only product in cutaneous dose form


name: Codeine and promethazine only product in oral dose form


name: Conjugated estrogen and esterified estrogen and medroxyprogesterone only product


name: Conjugated estrogen and esterified estrogen and medroxyprogesterone only product in oral dose form


name: Levonordefrin and mepivacaine only product


name: Levonordefrin and mepivacaine only product in parenteral dose form


name: Dexamethasone and hypromellose only product


name: Dexamethasone and hypromellose only product in ocular dose form


name: Dextran 40 only product in parenteral dose form


name: Drospirenone and ethinyl estradiol and levomefolic acid only product


name: Drospirenone and ethinyl estradiol and levomefolic acid only product in oral dose form


name: Epinephrine and prilocaine only product in parenteral dose form


name: Equine antithymocyte immunoglobulin only product


name: Equine antithymocyte immunoglobulin only product in parenteral dose form


name: Follitropin alfa only product in parenteral dose form


name: Human anti-D immunoglobulin only product


name: Human anti-D immunoglobulin only product in parenteral dose form


name: Isophane insulin and porcine regular insulin only product


name: Isophane insulin and porcine regular insulin only product in parenteral dose form


name: Isophane insulin and recombinant human regular insulin only product


name: Isophane insulin and recombinant human regular insulin only product in parenteral dose form


name: Miconazole and zinc oxide only product in cutaneous dose form


name: Para-aminohippuric acid only product in parenteral dose form


name: Acetaminophen and pentazocine only product


name: Acetaminophen and pentazocine only product in oral dose form


name: Acetaminophen and promethazine only product


name: Acetaminophen and promethazine only product in oral dose form


name: Pituitary follicle stimulating hormone and pituitary luteinizing hormone only product


name: Pituitary follicle stimulating hormone and pituitary luteinizing hormone only product in parenteral dose form


name: Prednicarbate only product in cutaneous dose form


name: Sodium ferric gluconate complex only product


name: Sodium ferric gluconate complex only product in parenteral dose form


name: Sodium thiosalicylate only product in parenteral dose form


name: Plain X-ray of all fingers of right hand


name: Administration of Haemophilus influenzae type b and hepatitis B vaccine


name: Cromolyn sodium 5 mg/actuation powder for inhalation


name: Ipratropium bromide 40 microgram/actuation powder for inhalation


name: Botulism immunoglobulin only product in parenteral dose form


name: Camphor and menthol and methyl salicylate only product in cutaneous dose form


name: Carbidopa and levodopa only product in oromucosal dose form


name: Carmustine only product in prolonged-release intralesional implant


name: Chloroxine only product in cutaneous dose form


name: Dyclonine only product in cutaneous dose form


name: Epinephrine and lidocaine only product in cutaneous dose form


name: Coagulation factor VIII and von Willebrand factor only product in parenteral dose form


name: Hexachlorophene only product in cutaneous dose form


name: Human chorionic gonadotropin only product in parenteral dose form


name: Lidocaine and prilocaine only product in dental dose form


name: Lutropin alfa only product in parenteral dose form


name: Mandelic acid only product in solution for irrigation


name: Menthol and methyl salicylate only product in cutaneous dose form


name: Mezlocillin only product in parenteral dose form


name: Noxythiolin only product in parenteral dose form


name: Piperacillin only product in parenteral dose form


name: Plicamycin only product in parenteral dose form


name: Procaine only product in parenteral dose form


name: Recombinant human antithrombin III only product in parenteral dose form


name: Salicylic acid and sulfur only product in cutaneous dose form


name: Sodium chloride only product in solution for irrigation


name: Ticarcillin only product in parenteral dose form


name: Human alpha1 proteinase inhibitor only product


name: Human alpha1 proteinase inhibitor only product in parenteral dose form


name: Cladribine only product in oral dose form


name: Administration of influenza vaccine via nasal route


name: Siponimod only product in oral dose form


name: Aclidinium- and formoterol-containing product


name: Aclidinium and formoterol only product in pulmonary dose form


name: Brexanolone only product in parenteral dose form


name: Solriamfetol only product in oral dose form


name: Specimen in non-fixative preservation fluid


name: Dolutegravir and lamivudine only product


name: Laparoscopic restorative proctocolectomy with ileal pouch anal anastomosis


name: Cytopathology procedure, imprint preparation


name: Preparation of large slide from specimen


name: Preparation of plastic embedded tissue specimen


name: Preparation of large size formalin fixed paraffin embedded tissue specimen


name: Preparation of formalin fixed paraffin embedded tissue specimen


name: Gross examination and sampling of tissue specimen


name: Mammography of bilateral breast specimens


name: Romosozumab only product in parenteral dose form


name: Administration of diphtheria and Haemophilus influenzae type b and pertussis and tetanus vaccine


name: International Health Terminology Standards Development Organisation periodontal module


name: Ascorbic acid supplement therapeutic role


name: Pantothenic acid supplement therapeutic role


name: Cyanocobalamin supplement therapeutic role


name: Portal vasculature pressure endoscopic needle


name: Patient transfer assistive bed and mobile chair


name: Capillary patient thermometer, gallium-alloy


name: Intervertebral disc prolapse repair implant


name: Gastrointestinal endoscopic clip, long-term, partially-bioabsorbable


name: Hematological concentrate cannula, open-surgery


name: Irreversible electroporation system bronchoscopic catheter


name: Anthraquinone glycoside and salicylic acid only product


name: Anthraquinone glycoside and salicylic acid only product in oromucosal dose form


name: Human C1 esterase inhibitor only product


name: Human C1 esterase inhibitor only product in parenteral dose form


name: Human protein C only product in parenteral dose form


name: Photographic image corrected intraoral mirrored visible record


name: Photographic image extraoral with mandible postured forward


name: Photographic image extraoral with 45 degree view


name: Erdafitinib only product in oral dose form


name: Risankizumab only product in parenteral dose form


name: Halobetasol and tazarotene only product in cutaneous dose form


name: Estimated required quantity of energy in 24 hours


name: Estimated intake of fruit servings in 24 hours


name: Estimated intake of grain servings in 24 hours


name: Estimated quantity of intake of saturated fat in 24 hours


name: Estimated quantity of intake of carbohydrate in 24 hours


name: Estimated quantity of intake of complex carbohydrate in 24 hours


name: Estimated quantity of intake of simple carbohydrate in 24 hours


name: Fixed Partial Denture (FPD) Retainer, Abutment Supported


name: Fixed Partial Denture (FPD) Retainer, Implant Supported


name: assessment of salivary flow by measurement


name: re-cement or re-bond bilateral space maintainer - maxillary


name: re-cement or re-bond bilateral space maintainer - mandibular


name: re-cement or re-bond unilateral space maintainer - per quadrant


name: removal of fixed unilateral space maintainer - per quadrant


name: removal of fixed bilateral space maintainer - maxillary


name: removal of fixed bilateral space maintainer - mandibular


name: crown - porcelain fused to titanium and titanium alloys


name: removable unilateral partial denture - one piece flexible base (including retentive/clasping materials, rests, and teeth) - per quadrant


name: removable unilateral partial denture - one piece resin (including retentive/clasping materials, rests, and teeth) - per quadrant


name: implant supported crown - porcelain fused to predominantly base alloys


name: implant supported crown - porcelain fused to noble alloys


name: implant supported crown - porcelain fused to titanium and titanium alloys


name: implant supported crown - predominantly base alloys


name: implant supported crown - titanium and titanium alloys


name: abutment supported crown - porcelain fused to titanium and titanium alloys


name: implant supported retainer - porcelain fused to predominantly base alloys


name: implant supported retainer for FPD - porcelain fused to noble alloys


name: implant supported retainer - porcelain fused to titanium and titanium alloys


name: implant supported retainer for metal FPD - predominantly base alloys


name: implant supported retainer for metal FPD - noble alloys


name: implant supported retainer for metal FPD - titanium and titanium alloys


name: abutment supported retainer - porcelain fused to titanium and titanium alloys


name: pontic - porcelain fused to titanium and titanium alloys


name: retainer crown - porcelain fused to titanium and titanium alloys


name: retainer crown ¾ - titanium and titanium alloys


name: placement of intra-socket biological dressing to aid in hemostasis or clot stabilization, per site


name: repair of orthodontic appliance - maxillary


name: repair of orthodontic appliance - mandibular


name: re-cement or re-bond fixed retainer - maxillary


name: re-cement or re-bond fixed retainer - mandibular


name: repair of fixed retainer, includes reattachment - maxillary


name: repair of fixed retainer, includes reattachment - mandibular


name: replacement of lost or broken retainer - maxillary


name: replacement of lost or broken retainer - mandibular


name: dental case management - patients with special health care needs


name: GAS2L2, 4-BP DEL, 887TAAG (dbSNP rs587633197)


name: CATSPERE, 6-BP DEL, 2393CTATGG (dbSNP rs761237686)


name: HNRNPK, 2-BP INS, 931TT (dbSNP SCV000258957)


name: Comfort EZ Short Needle 1ML 31G 5/16 inch Insulin Syringe


name: Global Easy Glide 1/2ML 31G 5/16 inch Insulin Syringe


name: Global Easy Glide 1ML 31G 5/16 inch Insulin Syringe


name: Global Easy Glide 3/10ML 31G 5/16 inch Insulin Syringe


name: Comfort EZ 32G 5/32 inch Micro Pen Needle


name: Comfort EZ 31G 5/16 inch Short Pen Needle


name: SoSweet Flavored Syrup Compounding Vehicle


name: Comfort EZ Short Needle 1/2ML 31G 5/16 inch Insulin Syringe


name: Advanced Eye Relief Dry Eye, preserved ophthalmic solution


name: lactobacillus rhamnosus GG-omega-3 fatty acids


name: Glucocard Shine Connex Blood Glucose Meter


name: Glucocard Shine Express Blood Glucose Meter


name: Dimethicone;Mometasone Furoate 5%; 0.1% Multiple Routes Cream [QUINIXIL]


name: Zinc Oxide;Cleanser;Lotion, Multi Ingredient;Lotion, Multi Ingredient;Shampoo, Multi Ingredient;Shampoo, Multi Ingredient 40%; NA; NA; NA; NA; NA Multiple Routes Kit [JOHNSON'S BATH DISCOVERY BABY GIFT SET]


name: Zinc Oxide;Cleanser;Lotion, Multi Ingredient;Lotion, Multi Ingredient;Shampoo, Multi Ingredient;Shampoo, Multi Ingredient 40%; NA; NA; NA; NA; NA Multiple Routes Kit


name: Benzoyl Peroxide;Clindamycin Phosphate;Octinoxate/Octisalate/Octocrylene/Oxybenzone/Titanium Dioxide 2.5%; 1%; 7.5%-5%-7%-6%-5.7% Multiple Routes Kit


name: Dexamethasone Sodium Phosphate;Isopropyl Alcohol;Povidone Iodine;Ropivacaine Hydrochloride 10 MG/1 ML; 70%; 10%; 5 MG/1 ML Multiple Routes Kit


name: Camphor/Menthol;Diclofenac Sodium 3%-3%; 75 MG Multiple Routes Kit


name: Clindamycin Phosphate;Octinoxate/Octisalate/Octocrylene/Oxybenzone/Titanium Dioxide 1%; 7.5%-5%-7%-6%-5.7% Multiple Routes Kit


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [Mary Kay TimeWise Repair Volu-Firm Day Cream Broad Spectrum SPF 30]


name: AVOBENZONE 15 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Aveeno Protect Plus Hydrate Sunscreen Broad Spectrum Body SPF 30]


name: HYALURONATE SODIUM 6.14 g in 100 mL TOPICAL PATCH [FUNEES]


name: HYALURONATE SODIUM 94.39 mg in 100 mg TOPICAL PATCH [PokePoke Patch]


name: TITANIUM DIOXIDE 22 mg in 1 mL / ZINC OXIDE 11 mg in 1 mL TOPICAL LOTION [WL-AAE-ZT-O-492]


name: HOMOSALATE 0.08 kg in 1 kg / OCTISALATE 0.05 kg in 1 kg / OCTOCRYLENE 0.055 kg in 1 kg / AVOBENZONE 0.03 kg in 1 kg TOPICAL LOTION [ASYSTEM Daily Defense Moisturizer SPF30]


name: OCTINOXATE 7.5 mg in 1 mL / TITANIUM DIOXIDE 3.6 mg in 1 mL / ZINC OXIDE 9 mg in 1 mL TOPICAL LIQUID [Revlon Colorstay Preo and Protect Primer]


name: ZINC OXIDE 20 g in 100 mL TOPICAL LOTION [SOLARA SUNCARE - TIME TRAVELER SPF-30 UNSCENTED]


name: Niacinamide 0.56 g in 28 mL / Adenosine 0.01 g in 28 mL TOPICAL PATCH [Voye Fresh Up Amazing Recovery Mask V Stemcell Recovery Ampule]


name: Niacinamide 0.56 g in 28 mL / Adenosine 0.01 g in 28 mL TOPICAL PATCH [Voye Fresh Up Perfect Moisture Mask V Hyaluron Moisture Ampule]


name: Niacinamide 0.56 g in 28 mL / Adenosine 0.01 g in 28 mL TOPICAL PATCH [Voye Fresh Up Real Lifting Mask V Tox Lifting Ampule]


name: OMEPRAZOLE SODIUM 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 2 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / OXYBENZONE 4 g in 100 mL TOPICAL LOTION [Mary Kay SunCare SPF 30 Sunscreen]


name: TITANIUM DIOXIDE 0.125 g in 1 g / ZINC OXIDE 0.225 g in 1 g TOPICAL POWDER [WL-AAI-ZT-P-522]


name: TITANIUM DIOXIDE 0.125 g in 1 g / ZINC OXIDE 0.225 g in 1 g TOPICAL POWDER [WL-AAI-ZT-P-523]


name: TITANIUM DIOXIDE 0.125 g in 1 g / ZINC OXIDE 0.225 g in 1 g TOPICAL POWDER [WL-AAI-ZT-P-524]


name: OXYBENZONE 60 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Equate SPF 70 Ultra Sunscreen]


name: AVOBENZONE 2 g in 100 mL / HOMOSALATE 5 g in 100 mL / OCTOCRYLENE 2 g in 100 mL / OCTISALATE 5 g in 100 mL / OXYBENZONE 4 g in 100 mL TOPICAL LOTION [MK Men Advanced Facial Hydrator Sunscreen SPF 30]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 9 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 2.75 g in 100 mL / OXYBENZONE 4.5 g in 100 mL TOPICAL LOTION [Botanical Effects Moisturizer SPF 30]


name: OCTINOXATE 7.4 g in 100 g / HOMOSALATE 6.2 g in 100 g / OCTISALATE 5.2 g in 100 g / OXYBENZONE 3.1 g in 100 g / AVOBENZONE 1.5 g in 100 g TOPICAL CREAM [Lavelier Divine Day Defense Broad Spectrum SPF 30]


name: OCTINOXATE 5.1 g in 100 g / TITANIUM DIOXIDE 6 g in 100 g TOPICAL POWDER [LA MER THE SOFT MOISTURE FOUNDATION BROAD SPECTRUM SPF 30]


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [WL-AAB-Z-W-330]


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [WL-AAB-Z-W-401]


name: ZINC OXIDE 95 mg in 1 mL TOPICAL LOTION [WL-AAS-Z-A-348]


name: (SPL REVIEW) cooling severe daytime cooling severe nighttime KIT


name: HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [Equate SPF 50 Ultra Sunscreen]


name: HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL TOPICAL EMULSION [Maybelline Dream Urban Cover Full Coverage Protective Make-Up SPF 50 Antioxidant-Enriched Pollution Protection]


name: HOMOSALATE 50 mg in 1 mL / OXYBENZONE 40 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL / AVOBENZONE 25 mg in 1 mL TOPICAL LOTION [Meijer SPF 30 Face]


name: HOMOSALATE 80 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL / OXYBENZONE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Meijer SPF 30 Ultra Dry Sheer]


name: TITANIUM DIOXIDE 50 mg in 1 mL / ZINC OXIDE 150 mg in 1 mL TOPICAL LOTION [La Roche Posay New 50 Body and Face SPF 50 Mineral Anthelios Gentle 100 percent mineral UV filters Soft finish with Cell Ox Shield]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 9 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 6 g in 100 mL TOPICAL LOTION [Olay Total Effects Moisturizer Broad Spectrum SPF 30]


name: HOMOSALATE 100 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Equate SPF 50 Ultra Sunscreen Continuous]


name: HOMOSALATE 150 mg in 1 g / OXYBENZONE 60 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Equate SPF 70 Ultra Sunscreen]


name: ZINC OXIDE 50.2125 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL TOPICAL LOTION [Equate SPF 50 Ultra Zinc Sunscreen]


name: Niacinamide 0.60 g in 30 mL / Adenosine 0.012 g in 30 mL TOPICAL CREAM [BOTANIC HEAL BOH DERMA SHOT VITAMIN EYE]


name: Niacinamide 1.00 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [BOTANIC HEAL BOH PROBIODERM REPAIR LIFTING]


name: Niacinamide 1.00 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL LIQUID [BOTANIC HEAL BOH PROBIODERM REPAIR AMPOULE SERUM]


name: Niacinamide 2.60 g in 130 mL / Adenosine 0.05 g in 130 mL TOPICAL CREAM [BOTANIC HEAL BOH DERMA SHOT VITAMIN ALL IN ONE ESSENCE]


name: OCTINOXATE 7.4 g in 100 g / HOMOSALATE 6.2 g in 100 g / OCTISALATE 5.0 g in 100 g / OXYBENZONE 3.1 g in 100 g / AVOBENZONE 1.5 g in 100 g TOPICAL CREAM [24K Skin Tone Moisturizer SPF 30]


name: Octinoxate 50 mg in 1 mL / Titanium dioxide 31 mg in 1 mL TOPICAL LIQUID [Ultra Le Teint Velvet Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen B10]


name: Octinoxate 50 mg in 1 mL / Titanium dioxide 42 mg in 1 mL TOPICAL LIQUID [Ultra Le Teint Velvet Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen BD121]


name: ZINC OXIDE 135.6 mg in 1 mL TOPICAL LOTION [WL-AAB-Z-W-471]


name: Niacinamide 0.60 g in 30 mL / Adenosine 0.01 g in 30 mL TOPICAL LIQUID [BOTANIC HEAL BOH DERMA INTENSIVE CICA PANTHENOL AMPOULE]


name: Niacinamide 2.40 g in 120 mL / Adenosine 0.04 g in 120 mL TOPICAL SPRAY [BOTANIC HEAL BOH DERMA INTENSIVE PANTHENOL CRE AM MIST]


name: Dimethicone 2.49 g in 120 mL TOPICAL LIQUID [ROUND AROUND ESSENTIAL BOOSTING HYDRATOR]


name: Niacinamide 0.80 g in 40 mL / Adenosine 0.01 g in 40 mL TOPICAL LIQUID [BRING GREEN Artemisia Calming Intensive Serum]


name: Niacinamide 1.50 g in 30 mL / Adenosine 0.01 g in 30 mL TOPICAL LIQUID [ROUND AROUND REPAIRING ACTIVE SERUM]


name: Niacinamide 1.80 g in 45 mL / Adenosine 0.018 g in 45 mL TOPICAL LIQUID [BRING GREEN CARROT VITA DARK SPOT SERUM]


name: ZINC OXIDE 150 mg in 1 g TOPICAL STICK [WL-AAC-Z-A-567]


name: ZINC OXIDE 135.6 mg in 1 mL TOPICAL LOTION [Sunforgettable Total Protection Face Shield Bronze]


name: Diclofenac Sodium;Lidocaine 75 MG; 5% Multiple Routes Kit [LIDOVIX]


name: AVOBENZONE 1.5 g in 50 g / OCTOCRYLENE 3.75 g in 50 g / OCTISALATE 2.5 g in 50 g TOPICAL CREAM [No7 Protect and Perfect Intense Advanced Day Cream Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 112 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL SPRAY [BABYGANICS SPF 50 Plus SUNSCREEN]


name: AMINOHIPPURIC ACID 1 g in 1 g NOT APPLICABLE POWDER


name: CHLORAMBUCIL 1 g in 1 g NOT APPLICABLE POWDER


name: IMATINIB MESYLATE 1 g in 1 g NOT APPLICABLE POWDER


name: PAROMOMYCIN SULFATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: PREDNISOLONE SODIUM PHOSPHATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: RIFABUTIN 1 g in 1 g NOT APPLICABLE POWDER


name: SECNIDAZOLE 1 kg in 1 kg NOT APPLICABLE POWDER


name: TYLOSIN 1 kg in 1 kg NOT APPLICABLE POWDER


name: Niacinamide 2.60 g in 130 mL TOPICAL LIQUID [AAPE Nutrient Facial Toner]


name: SERTRALINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: Adenosine 0.005 g in 0.55 g TOPICAL PATCH [FILL ME MICRO NEEDLE]


name: ZINC OXIDE 230 mg in 1 g TOPICAL LOTION [Raw Elements Eco Formula SPF30 Sample Packs]


name: Niacinamide 0.80 g in 40 mL / Adenosine 0.01 g in 40 mL TOPICAL LIQUID [AAPE Continuous Renewal Serum]


name: Betiatide 1 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Kit for the Preparation of Technetium Tc99m Mertiatide]


name: kit for prep Tc-99m-labeled red blood cells INTRAVEN VIAL (EA)


name: influenza A virus A/Idaho/07/2018 (H1N1) antigen / influenza A virus A/Indiana/08/2018 (H3N2) antigen / influenza B virus B/Iowa/06/2017 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen


name: camphor / dimethicone / lidocaine / menthol


name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4


name: SUCTION TUBE ATTACHMENT DEVICE KENDALL #166004


name: CATHETER,INTERMITTENT,MAGIC3 14FR BARD #53814G


name: SET,INFUSION,FLOW REGULATOR,12IN STAT 2 #S2-12


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002822


name: SET,INFUSION AUTOSOFT 30 TANDEM #1002825


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002819


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002818


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002821


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002820


name: SET,INFUSION AUTOSOFT 30 TANDEM #1002826


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM650


name: TRACH STOMA TRACHEOFIX ADHESIVE STRIP LUMINAUD #63046


name: TRACH STOMA PROTECTOR,BUCHANAN LITE LUMINAUD #38220


name: DRESSING,TEGADERM ISLAND 2IN X 2.75IN 3M#3582


name: HEAT & MOISTURE EXCHANGER MALLINCKRODT #353U19004


name: URINE METER WITH CATHETER 16FR BARD #892816


name: CATHETER,FOLEY COUDE 16FR 30ML BARD#0100L-16


name: Two-Item Generalised Anxiety Disorder Scale


name: Prolonged Intermittent Renal Replacement Therapy


name: Sustained Low-Efficiency Daily Diafiltration


name: Hydrogen Deuterium Exchange-Mass Spectrometry


name: Observational Studies, Veterinary as Topic


name: lamivudine, tenofovir disoproxil fumarate drug combination


name: lidocaine-cetylpyridinium chloride drug combination


name: Computational Prediction of Drug-Target Interactions


name: Tumor Necrosis Factor-a (TNF-a) Antagonists


name: Tumor Necrosis Factor-a (TNF-a) Inhibitors


name: Tumor Necrosis Factor-a (TNF-a) Blockers


name: Thyrotroph Thyroid Hormone Sensitivity Index


name: Polymerase Acidic Endonuclease Inhibitor


name: Was there a History of Radiation Exposure


name: heparin flush 1 unit/mL-NaCl 0.9% intravenous solution


name: heparin flush 1 units/mL intravenous solution


name: heparin flush 1 unit/mL-NaCl 0.45% intravenous solution


name: Aldosterone [Mass or Moles/volume] in Serum or Plasma


name: Aldosterone [Mass or Moles/volume] in Urine


name: Aldosterone [Mass or Moles/volume] in Serum or Plasma --supine


name: Androstanolone [Mass or Moles/volume] in Serum or Plasma


name: Bilirubin.direct [Mass or Moles/volume] in Serum or Plasma


name: Bilirubin.indirect [Mass or Moles/volume] in Serum or Plasma


name: Bilirubin.total [Mass or Moles/volume] in Body fluid


name: Cortisol [Mass or Moles/volume] in Serum or Plasma


name: Creatinine [Mass or Moles/volume] in Urine


name: Creatinine [Mass or Moles] in 24 hour Urine


name: Estrone (E1) [Mass or Moles/volume] in Serum or Plasma


name: Glucagon [Mass or Moles/volume] in Serum or Plasma


name: carBAMazepine [Mass or Moles/volume] in Serum or Plasma


name: Ethanol [Mass or Moles/volume] in Serum or Plasma


name: Fowler operation release for mallet finger repair


name: Bilirubin.total [Mass or Moles/volume] in Serum or Plasma


name: Estradiol (E2) [Mass or Moles/volume] in Serum or Plasma


name: heparin flush 2 units/mL-NaCl 0.9% intravenous solution


name: HEPARIN NA 100UNT/ML (PF) LOCK FLUSH SOLN,SYRINGE,5ML


name: HEPARIN NA 100UNT/ML (PF) LOCK FLUSH SOLN,SYRINGE,3ML


name: HEPARIN NA 10UNT/ML (PF) LOCK FLUSH SOLN,SYRINGE,3ML


name: HEPARIN SODIUM 10 [USP'U] in 1 mL INTRAVENOUS INJECTION, SOLUTION (device)


name: Sodium Chloride 0.9% Intravenous Solution [BD POSIFLUSH SF]


name: SODIUM CHLORIDE 0.9% INJ,SYR,10ML POSIFLUSH


name: Calcium [Mass or Moles/volume] in Serum or Plasma


name: Calcium [Mass or Moles/volume] in 24 hour Urine


name: Creatinine [Mass or Moles/volume] in 24 hour Urine


name: Ammonia [Mass or Moles/volume] in Plasma


name: Calcium [Mass or Moles/volume] corrected for total protein in Serum or Plasma


name: Cortisol Free [Mass or Moles/volume] in 24 hour Urine by HPLC


name: XR Hip - left Views and Lateral crosstable


name: XR Radius and Ulna - right Views and Oblique


name: XR Hip - right Views and Lateral crosstable


name: XR Tibia and Fibula - right Views and Oblique


name: Calcium.ionized [Mass or Moles/volume] in Serum or Plasma


name: Heparin Sodium 10 U/1 ML Intravenous Solution [VASCEZE HEPARIN LOCK FLUSH]


name: Guidance for injection of Spine facet joint


name: BD Normal Saline Flush, 0.9% injectable solution


name: Normal Saline Flush, 0.9% injectable solution


name: heparin flush 4 units/mL-NaCl 0.9% intravenous solution


name: HEPARIN NA 2000UNT/ML LOCK FLUSH SOLN,SYRINGE,3ML


name: Sodium Chloride 0.9% Intravenous Solution [MONOJECT SODIUM CHLORIDE FLUSH SYRINGE]


name: Sodium Chloride 0.9% Injection Solution [SYREX]


name: sodium chloride 0.9 % (flush) 0.9 % INJECTION SYRINGE, WITH SWAB CAP (ML)


name: heparin flush 5 units/mL-NaCl 0.9% intravenous solution


name: Padimate O/Petrolatum, White 1.5%-44% Topical application Stick [LEADER LIP BALM]


name: Heparin Lock Flush, 1 units/mL intravenous solution


name: CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, full gene sequence (List separately in addition to code for primary procedure)


name: Grafting of autologous soft tissue, other, harvested by direct excision (eg, fat, dermis, fascia)


name: Grafting of autologous dermis, harvested by direct excision


name: Grafting of autologous fascia, harvested by direct excision


name: Grafting of autologous fat, harvested by direct excision


name: Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs


name: Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; 50 cc or less injectate


name: Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; each additional 50 cc injectate, or part thereof (List separately in addition to code for primary procedure)


name: Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, and/or feet


name: Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, and/or feet; 25 cc or less injectate


name: Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, and/or feet; each additional 25 cc injectate, or part thereof (List separately in addition to code for primary procedure)


name: Needle insertion(s) without injection(s); 1 or 2 muscle(s)


name: Insertion of needle in 2 muscles without injection


name: Needle insertion(s) without injection(s); 3 or more muscles


name: Insertion of needle in 3 or more muscles


name: Manual preparation and insertion of drug-delivery device(s), deep (eg, subfascial) (List separately in addition to code for primary procedure)


name: Manual preparation and insertion of deep drug delivery device into muscle


name: Manual preparation and insertion of deep drug delivery devices into muscle


name: Removal of drug-delivery device(s), deep (eg, subfascial) (List separately in addition to code for primary procedure)


name: Removal of drug-delivery devices from beneath fibrous covering of muscle


name: Manual preparation and insertion of drug-delivery device(s), intramedullary (List separately in addition to code for primary procedure)


name: Manual preparation and insertion of intramedullary drug delivery device into bone


name: Manual preparation and insertion of intramedullary drug delivery devices into bone


name: Removal of drug-delivery device(s), intramedullary (List separately in addition to code for primary procedure)


name: Removal of drug-delivery devices from marrow cavity of bone


name: Removal of intramedullary drug delivery device from bone


name: Removal of intramedullary drug delivery devices from bone


name: Manual preparation and insertion of drug-delivery device(s), intra-articular (List separately in addition to code for primary procedure)


name: Manual preparation and insertion of intra-articular drug delivery device into joint


name: Manual preparation and insertion of intra-articular drug delivery devices into joint


name: Removal of drug-delivery device(s), intra-articular (List separately in addition to code for primary procedure)


name: Removal of drug-delivery devices into joint


name: Removal of intra-articular drug delivery device from joint


name: Removal of intra-articular drug delivery devices from joint


name: Excision of chest wall tumor involving rib(s), with plastic reconstruction; without mediastinal lymphadenectomy


name: Excision of neoplasm of chest wall including rib with plastic reconstruction


name: Excision of neoplasm of chest wall including ribs with plastic reconstruction


name: Excision of neoplasm of chest wall including ribs with plastic reconstruction and mediastinal lymphadenectomy


name: Nasal/sinus endoscopy, surgical, with orbital decompression


name: Nasal/sinus endoscopy, surgical, with dilation (eg, balloon dilation)


name: Surgical endoscopy of nose and sinus with dilation of frontal sinus ostium


name: Surgical endoscopy of nose and sinus with dilation of sphenoid sinus ostium


name: Pericardiocentesis, including imaging guidance, when performed


name: Pericardiocentesis using imaging guidance


name: Pericardial drainage with insertion of indwelling catheter, percutaneous, including fluoroscopy and/or ultrasound guidance, when performed


name: Pericardial drainage with insertion of indwelling catheter, percutaneous, including fluoroscopy and/or ultrasound guidance, when performed; 6 years and older without congenital cardiac anomaly


name: Pericardial drainage with insertion of indwelling catheter, percutaneous, including fluoroscopy and/or ultrasound guidance, when performed; birth through 5 years of age or any age with congenital cardiac anomaly


name: Pericardial drainage with insertion of indwelling catheter, percutaneous, including CT guidance


name: Transcatheter removal of permanent leadless pacemaker, right ventricular, including imaging guidance (eg, fluoroscopy, venous ultrasound, ventriculography, femoral venography), when performed


name: Transcatheter removal of permanent leadless pacemaker from right ventricle using imaging guidance


name: Ascending aorta graft, with cardiopulmonary bypass, includes valve suspension, when performed


name: Ascending aorta graft, with cardiopulmonary bypass, includes valve suspension, when performed; for aortic dissection


name: Insertion of graft in ascending aorta for dissection of aorta with suspension of aortic valve, with cardiopulmonary bypass


name: Insertion of graft in ascending aorta for dissection of aorta with cardiopulmonary bypass


name: Ascending aorta graft, with cardiopulmonary bypass, includes valve suspension, when performed; for aortic disease other than dissection (eg, aneurysm)


name: Insertion of graft in ascending aorta for aneurysm, with cardiopulmonary bypass


name: Insertion of graft in ascending aorta for aneurysm, with suspension of aortic valve, with cardiopulmonary bypass


name: Insertion of graft in ascending aorta for disease of aorta other than dissection, with cardiopulmonary bypass


name: Transverse aortic arch graft, with cardiopulmonary bypass, with profound hypothermia, total circulatory arrest and isolated cerebral perfusion with reimplantation of arch vessel(s) (eg, island pedicle or individual arch vessel reimplantation)


name: Insertion of graft in transverse arch of aorta, with cardiopulmonary bypass, with profound hypothermia, total circulatory arrest, and isolated cerebral perfusion with individual reimplantation of arch vessels


name: Insertion of graft in transverse arch of aorta, with cardiopulmonary bypass, with profound hypothermia, total circulatory arrest, and isolated cerebral perfusion with island pedicle reimplantation of arch vessel


name: Insertion of graft in transverse arch of aorta, with cardiopulmonary bypass, with profound hypothermia, total circulatory arrest, and isolated cerebral perfusion with island pedicle reimplantation of arch vessels


name: Endovascular repair of iliac artery at the time of aorto-iliac artery endograft placement by deployment of an iliac branched endograft including pre-procedure sizing and device selection, all ipsilateral selective iliac artery catheterization(s), all associated radiological supervision and interpretation, and all endograft extension(s) proximally to the aortic bifurcation and distally in the internal iliac, external iliac, and common femoral artery(ies), and treatment zone angioplasty/stenting, when performed, for rupture or other than rupture (eg, for aneurysm, pseudoaneurysm, dissection, arteriovenous malformation, penetrating ulcer, traumatic disruption), unilateral (List separately in addition to code for primary procedure)


name: Endovascular repair of iliac artery, not associated with placement of an aorto-iliac artery endograft at the same session, by deployment of an iliac branched endograft, including pre-procedure sizing and device selection, all ipsilateral selective iliac artery catheterization(s), all associated radiological supervision and interpretation, and all endograft extension(s) proximally to the aortic bifurcation and distally in the internal iliac, external iliac, and common femoral artery(ies), and treatment zone angioplasty/stenting, when performed, for other than rupture (eg, for aneurysm, pseudoaneurysm, dissection, arteriovenous malformation, penetrating ulcer), unilateral


name: Exploration not followed by surgical repair, artery


name: Exploration not followed by surgical repair, artery; upper extremity (eg, axillary, brachial, radial, ulnar)


name: Exploration of artery of upper extremity


name: Exploration not followed by surgical repair, artery; lower extremity (eg, common femoral, deep femoral, superficial femoral, popliteal, tibial, peroneal)


name: Exploration of artery of lower extremity


name: Tying of single internal hemorrhoid group


name: Tying of multiple internal hemorrhoid groups


name: Hemorrhoidectomy, internal, by transanal hemorrhoidal dearterialization, 2 or more hemorrhoid columns/groups, including ultrasound guidance, with mucopexy, when performed


name: Internal hemorrhoidectomy by transanal dearterialization of multiple hemorrhoid columns using ultrasound guidance


name: Internal hemorrhoidectomy by transanal dearterialization of multiple hemorrhoid columns using ultrasound guidance, with mucopexy


name: Internal hemorrhoidectomy by transanal dearterialization of multiple hemorrhoid groups using ultrasound guidance


name: Internal hemorrhoidectomy by transanal dearterialization of multiple hemorrhoid groups using ultrasound guidance, with mucopexy


name: Preperitoneal pelvic packing for hemorrhage associated with pelvic trauma, including local exploration


name: Exploration and packing of wound in pelvic region


name: Preperitoneal pelvic packing for hemorrhage associated with pelvic trauma, with local exploration


name: Re-exploration of pelvic wound with removal of preperitoneal pelvic packing, including repacking, when performed


name: Re-exploration of pelvic wound with removal of preperitoneal pelvic packing


name: Re-exploration of pelvic wound with removal of preperitoneal pelvic packing and repacking


name: Spinal puncture, lumbar, diagnostic; with fluoroscopic or CT guidance


name: Diagnostic puncture of lumbar spine using fluoroscopic guidance


name: Spinal puncture, therapeutic, for drainage of cerebrospinal fluid (by needle or catheter); with fluoroscopic or CT guidance


name: Injection(s), anesthetic agent(s) and/or steroid


name: Injection(s), anesthetic agent(s) and/or steroid; trigeminal nerve, each branch (ie, ophthalmic, maxillary, mandibular)


name: Injection(s), anesthetic agent(s) and/or steroid; greater occipital nerve


name: Injection of anesthetic agent and steroid into greater occipital nerve


name: Injection of steroid into greater occipital nerve


name: Injection(s), anesthetic agent(s) and/or steroid; vagus nerve


name: Injection of anesthetic agent and/or steroid into vagus nerve


name: Injection of anesthetic agent and steroid into vagus nerve


name: Injection(s), anesthetic agent(s) and/or steroid; brachial plexus, including imaging guidance, when performed


name: Injection of anesthetic agent and steroid into brachial plexus


name: Injection of steroid into brachial plexus


name: Injection(s), anesthetic agent(s) and/or steroid; axillary nerve, including imaging guidance, when performed


name: Injection of anesthetic agent and/or steroid into upper arm and shoulder nerve (axillary nerve)


name: Injection of anesthetic agent and steroid into axillary nerve


name: Injection(s), anesthetic agent(s) and/or steroid; suprascapular nerve


name: Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve


name: Injection of anesthetic agent and steroid into suprascapular nerve


name: Injection of steroid into suprascapular nerve


name: Injection(s), anesthetic agent(s) and/or steroid; intercostal nerve, single level


name: Injection(s), anesthetic agent(s) and/or steroid; intercostal nerve, each additional level (List separately in addition to code for primary procedure)


name: Injection of anesthetic agent and steroid into intercostal nerve, each additional level


name: Injection of anesthetic agent into intercostal nerve, each additional level


name: Injection of steroid into intercostal nerve, each additional level


name: Injection(s), anesthetic agent(s) and/or steroid; ilioinguinal, iliohypogastric nerves


name: Injection of anesthetic agent and steroid into ilioinguinal nerves


name: Injection of steroid into iliohypogastric and ilioinguinal nerves


name: Injection of steroid into iliohypogastric nerve


name: Injection of steroid into ilioinguinal nerve


name: Injection(s), anesthetic agent(s) and/or steroid; pudendal nerve


name: Injection of anesthetic agent and steroid into pudendal nerve


name: Injection of steroid into pudendal nerve


name: Injection(s), anesthetic agent(s) and/or steroid; paracervical (uterine) nerve


name: Injection of anesthetic agent and steroid into paracervical nerve of uterus


name: Injection of steroid into paracervical nerve of uterus


name: Injection(s), anesthetic agent(s) and/or steroid; sciatic nerve, including imaging guidance, when performed


name: Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve)


name: Injection of anesthetic agent and steroid into sciatic nerve


name: Injection of anesthetic agent and steroid into femoral nerve


name: Injection of anesthetic agent and steroid into branch of peripheral nerve


name: Injection of anesthetic agent and steroid into peripheral nerve


name: Injection of anesthetic agent into branch of peripheral nerve


name: Injection of steroid into branch of peripheral nerve


name: Injection of steroid into peripheral nerve


name: Injection(s), anesthetic agent(s) and/or steroid; nerves innervating the sacroiliac joint, with image guidance (ie, fluoroscopy or computed tomography)


name: Injection of anesthetic agent and steroid into nerves innervating sacroiliac joint using fluoroscopic guidance


name: Injection of anesthetic agent into nerves innervating sacroiliac joint using fluoroscopic guidance


name: Injection of steroid into nerves innervating sacroiliac joint using fluoroscopic guidance


name: Injection(s), anesthetic agent(s) and/or steroid; genicular nerve branches, including imaging guidance, when performed


name: Injection of anesthetic agent and steroid into branches of genicular nerve


name: Injection of anesthetic agent and steroid into branches of genicular nerve using imaging guidance


name: Injection of anesthetic agent into branches of genicular nerve


name: Injection of anesthetic agent into branches of genicular nerve using imaging guidance


name: Injection of steroid into branches of genicular nerve


name: Injection of steroid into branches of genicular nerve using imaging guidance


name: Destruction by neurolytic agent, genicular nerve branches including imaging guidance, when performed


name: Destruction by neurolytic agent of branches of genicular nerve


name: Destruction by neurolytic agent of branches of genicular nerve using imaging guidance


name: Radiofrequency ablation, nerves innervating the sacroiliac joint, with image guidance (ie, fluoroscopy or computed tomography)


name: Extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (eg, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage


name: Complex 1-stage extracapsular cataract removal by irrigation and aspiration with insertion of intraocular lens prosthesis and iris expansion device


name: Complex 1-stage extracapsular cataract removal by irrigation and aspiration with insertion of intraocular lens prosthesis and primary posterior capsulorrhexis


name: Complex 1-stage extracapsular cataract removal by irrigation and aspiration with insertion of intraocular lens prosthesis with suture support


name: Complex 1-stage extracapsular cataract removal by irrigation and aspiration, on patient in the amblyogenic developmental stage


name: Complex 1-stage extracapsular cataract removal by manual technique with insertion of intraocular lens prosthesis and iris expansion device


name: Complex 1-stage extracapsular cataract removal by manual technique with insertion of intraocular lens prosthesis and primary posterior capsulorrhexis


name: Complex 1-stage extracapsular cataract removal by manual technique with insertion of intraocular lens prosthesis with suture support


name: Complex 1-stage extracapsular cataract removal by manual technique with insertion of intraocular lens prosthesis, on patient in the amblyogenic developmental stage


name: Complex 1-stage extracapsular cataract removal by mechanical technique with insertion of intraocular lens prosthesis and iris expansion device


name: Complex 1-stage extracapsular cataract removal by mechanical technique with insertion of intraocular lens prosthesis and primary posterior capsulorrhexis


name: Complex 1-stage extracapsular cataract removal by mechanical technique with insertion of intraocular lens prosthesis with suture support


name: Complex 1-stage extracapsular cataract removal by mechanical technique with insertion of intraocular lens prosthesis, on patient in the amblyogenic developmental stage


name: Complex 1-stage extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis and iris expansion device


name: Complex 1-stage extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis and primary posterior capsulorrhexis


name: Complex 1-stage extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis with suture support


name: Complex 1-stage extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis, on patient in the amblyogenic developmental stage


name: Extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (eg, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage; with endoscopic cyclophotocoagulation


name: Complex 1-stage extracapsular cataract removal by irrigation and aspiration, with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis and iris expansion device


name: Complex 1-stage extracapsular cataract removal by irrigation and aspiration, with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis and primary posterior capsulorrhexis


name: Complex 1-stage extracapsular cataract removal by irrigation and aspiration, with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis with suture support


name: Complex 1-stage extracapsular cataract removal by irrigation and aspiration, with endoscopic cyclophotocoagulation and insertion of intraocular lens, on patient in the amblyogenic developmental stage


name: Complex 1-stage extracapsular cataract removal by manual technique, with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis and iris expansion device


name: Complex 1-stage extracapsular cataract removal by manual technique, with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis with suture support


name: Complex 1-stage extracapsular cataract removal by manual technique, with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis, on patient in the amblyogenic developmental stage


name: Complex 1-stage extracapsular cataract removal by manual technique, with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis, with primary posterior capsulorrhexis


name: Complex 1-stage extracapsular cataract removal by phacoemulsification, with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis and iris expansion device


name: Complex 1-stage extracapsular cataract removal by phacoemulsification, with endoscopic cyclophotocoagulation and insertion of intraocular lens, on patient in the amblyogenic developmental stage


name: Complex 1-stage extracapsular cataract removal by phacoemulsification, with endoscopic cyclophotocoagulation with insertion of intraocular lens prosthesis and primary posterior capsulorrhexis


name: Complex 1-stage extracapsular cataract removal by phacoemulsification, with endoscopic cyclophotocoagulation with insertion of intraocular lens prosthesis with suture support


name: Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification)


name: 1-stage extracapsular cataract removal by irrigation and aspiration with insertion of intraocular lens prosthesis


name: 1-stage extracapsular cataract removal by mechanical technique with insertion of intraocular lens prosthesis


name: Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); with endoscopic cyclophotocoagulation


name: 1-stage extracapsular cataract removal by irrigation and aspiration with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis


name: 1-stage extracapsular cataract removal by mechanical technique with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis


name: 1-stage extracapsular cataract removal by phacoemulsification with endoscopic cyclophotocoagulation and insertion of intraocular lens prosthesis


name: Complete acute abdomen x-ray series, erect and decubitus views, and anteroposterior chest view


name: Complete acute abdomen x-ray series, erect and decubitus views, and single chest view


name: Complete acute abdomen x-ray series, supine and decubitus views, and anteroposterior chest view


name: Complete acute abdomen x-ray series, supine and decubitus views, and single chest view


name: Complete acute abdomen x-ray series, supine and erect views, and anteroposterior chest view


name: Complete acute abdomen x-ray series, supine and erect views, and single chest view


name: Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed


name: Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study


name: X-ray study of esophagus with barium, with scout x-ray of chest and delayed image


name: Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; double-contrast (eg, high-density barium and effervescent agent) study


name: X-ray study of esophagus with double contrast


name: X-ray study of esophagus with double contrast, with scout x-ray of chest and delayed image


name: X-ray study of esophagus with high-density barium and effervescent agent contrast


name: X-ray study of esophagus with high-density barium and effervescent agent contrast, with scout x-ray of chest and delayed image


name: Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study


name: X-ray study of swallowing function with contrast, with cineradiography


name: Radiologic examination, upper gastrointestinal tract, including scout abdominal radiograph(s) and delayed image(s), when performed


name: Single contrast X-ray of upper digestive tract


name: X-ray of upper gastrointestinal tract with barium


name: X-ray of upper gastrointestinal tract with barium, with scout x-ray of abdomen and delayed image


name: X-ray of upper gastrointestinal tract with single contrast


name: X-ray of upper gastrointestinal tract with single contrast, with scout x-ray of abdomen and delayed image


name: Double contrast X-ray of upper digestive tract


name: X-ray of upper gastrointestinal tract with double contrast


name: X-ray of upper gastrointestinal tract with double contrast, with scout x-ray of abdomen and delayed image


name: X-ray of upper gastrointestinal tract with double contrast, with scout x-ray of abdomen and delayed image and administration of glucagon


name: X-ray of upper gastrointestinal tract with double contrast, with scout x-rays of abdomen and delayed images


name: X-ray of upper gastrointestinal tract with specific high density barium and effervescent agent contrast, with scout x-ray of abdomen and delayed image


name: Radiologic small intestine follow-through study, including multiple serial images (List separately in addition to code for primary procedure for upper GI radiologic examination)


name: Follow-through x-ray of small intestine with multiple serial images


name: Radiologic examination, small intestine, including multiple serial images and scout abdominal radiograph(s), when performed


name: Radiologic examination, small intestine, including multiple serial images and scout abdominal radiograph(s), when performed; single-contrast (eg, barium) study


name: X-ray of small intestine with single contrast, with multiple serial films


name: X-ray of small intestine with single contrast, with scout x-ray of abdomen and delayed image


name: X-ray of small intestine with double contrast and administration of glucagon


name: X-ray of small intestine with double contrast, with scout x-ray of abdomen and multiple serial films and administration of glucagon


name: X-ray of small intestine with high-density barium and air contrast administered via enteroclysis tube


name: X-ray of small intestine with high-density barium and air contrast administered via enteroclysis tube and administration of glucagon


name: X-ray of small intestine with high-density barium and air contrast administered via enteroclysis tube, with scout x-ray of abdomen and multiple serial films


name: X-ray of small intestine with high-density barium and air contrast administered via enteroclysis tube, with scout x-ray of abdomen and multiple serial films and administration of glucagon


name: Radiologic examination, colon, including scout abdominal radiograph(s) and delayed image(s), when performed


name: X-ray of colon with barium contrast, with scout x-ray of abdomen and delayed image


name: X-ray of colon with specific high density barium and air contrast


name: X-ray of colon with specific high density barium and air contrast, with scout x-ray of abdomen and delayed image


name: X-ray of colon with specific high density barium and air contrast, with administration of glucagon


name: X-ray of colon with specific high density barium and air contrast, with scout x-ray of abdomen and delayed image and administration of glucagon


name: Myocardial imaging, positron emission tomography (PET), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single study; with concurrently acquired computed tomography transmission scan


name: Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed)


name: Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at rest or stress (exercise or pharmacologic), with concurrently acquired computed tomography transmission scan


name: Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic), with concurrently acquired computed tomography transmission scan


name: Myocardial imaging, positron emission tomography (PET), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), dual radiotracer (eg, myocardial viability)


name: Myocardial imaging, positron emission tomography (PET), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), dual radiotracer (eg, myocardial viability); with concurrently acquired computed tomography transmission scan


name: Absolute quantitation of myocardial blood flow (AQMBF), positron emission tomography (PET), rest and pharmacologic stress (List separately in addition to code for primary procedure)


name: Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed)


name: Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, single area (eg, head, neck, chest, pelvis), single day imaging


name: Planar imaging of distribution of radiopharmaceutical agent in chest, single day


name: Planar imaging of distribution of radiopharmaceutical agent in chest, with vascular flow and blood pool imaging, single day


name: Planar imaging of distribution of radiopharmaceutical agent in head, single day


name: Planar imaging of distribution of radiopharmaceutical agent in head, with vascular flow and blood pool imaging, single day


name: Planar imaging of distribution of radiopharmaceutical agent in limited area, single day


name: Planar imaging of distribution of radiopharmaceutical agent in limited area, with vascular flow and blood pool imaging, single day


name: Planar imaging of distribution of radiopharmaceutical agents in neck, with vascular flow and blood pool imaging, single day


name: Planar imaging of distribution of radiopharmaceutical agent in neck, single day


name: Planar imaging of distribution of radiopharmaceutical agent in pelvis, with vascular flow and blood pool imaging, single day


name: Planar imaging of distribution of radiopharmaceutical agents in chest, single day


name: Planar imaging of distribution of radiopharmaceutical agents in chest, with vascular flow and blood pool imaging, single day


name: Planar imaging of distribution of radiopharmaceutical agents in head, single day


name: Planar imaging of distribution of radiopharmaceutical agents in head, with vascular flow and blood pool imaging, single day


name: Planar imaging of distribution of radiopharmaceutical agents in limited area, with vascular flow and blood pool imaging, single day


name: Planar imaging of distribution of radiopharmaceutical agent in neck, with vascular flow and blood pool imaging, single day


name: Planar imaging of distribution of radiopharmaceutical agents in neck, single day


name: Planar imaging of distribution of radiopharmaceutical agents in pelvis, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of inflammation in chest, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of inflammation in chest, single day


name: Planar imaging radiopharmaceutical localization of inflammation in head, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of inflammation in head, single day


name: Planar imaging radiopharmaceutical localization of inflammation in limited area, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of inflammation in limited area, single day


name: Planar imaging radiopharmaceutical localization of inflammation in neck, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of inflammation in neck, single day


name: Planar imaging radiopharmaceutical localization of inflammation in pelvis, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of inflammation in pelvis, single day


name: Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, 2 or more areas (eg, abdomen and pelvis, head and chest), 1 or more days imaging or single area imaging over 2 or more days


name: Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, whole body, single day imaging


name: Planar imaging distribution of radiopharmaceutical agent in entire body, single day


name: Planar imaging distribution of radiopharmaceutical agents, with vascular flow and blood pool imaging in entire body, single day


name: Planar imaging distribution of radiopharmaceutical agents in entire body, single day


name: Planar imaging distribution of radiopharmaceutical agent, with vascular flow and blood pool imaging in entire body, single day


name: Planar imaging radiopharmaceutical localization of inflammation in entire body, single day


name: Planar imaging radiopharmaceutical localization of inflammation, with vascular flow and blood pool imaging in entire body, single day


name: Planar imaging distribution of radiopharmaceutical agent in entire body, multiple days


name: Planar imaging distribution of radiopharmaceutical agents in entire body, multiple days


name: Planar imaging distribution of radiopharmaceutical agent in entire body, with vascular flow and blood pool imaging, multiple days


name: Planar radiopharmaceutical localization of inflammation in entire body with vascular flow and blood pool imaging, multiple days


name: Planar radiopharmaceutical localization of inflammation in entire body, multiple days


name: Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, single area (eg, head, neck, chest, pelvis) or acquisition, single day imaging


name: Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT), minimum 2 areas (eg, pelvis and knees, chest and abdomen) or separate acquisitions (eg, lung ventilation and perfusion), single day imaging, or single area or acquisition over 2 or more days


name: Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, minimum 2 areas (eg, pelvis and knees, chest and abdomen) or separate acquisitions (eg, lung ventilation and perfusion), single day imaging, or single area or acquisition over 2 or more days


name: Radiopharmaceutical quantification measurement(s) single area (List separately in addition to code for primary procedure)


name: Radiopharmaceutical quantification measurement of single area


name: Drug test(s), presumptive, any number of drug classes, any number of devices or procedures


name: Cytogenomic neoplasia (genome-wide) microarray analysis, interrogation of genomic regions for copy number and loss-of-heterozygosity variants for chromosomal abnormalities


name: Cytogenomic neoplasia (genome-wide) microarray analysis wih interrogation of genomic regions for copy number and loss-of-heterozygosity variants for chromosomal abnormalities


name: PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) gene analysis


name: PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) gene analysis; full gene sequence


name: Gene analysis (partner and localizer of BRCA2) full sequence analysis


name: Partner and localizer of BRCA2 (PALB2) full gene sequence analysis


name: PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) gene analysis; known familial variant


name: Gene analysis (partner and localizer of BRCA2) for detection of known familial variant


name: Partner and localizer of BRCA2 (PALB2) gene analysis for detection of known familial variant


name: PIK3CA (phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha) (eg, colorectal and breast cancer) gene analysis, targeted sequence analysis (eg, exons 7, 9, 20)


name: Gene analysis (partner and localizer of BRCA2) targeted sequence analysis


name: Phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha (PIK3CA) targeted gene sequence analysis


name: Gene analysis (UDP glucuronosyltransferase 1 family, polypeptide A1) for detection of common variants


name: Oncology (breast), mRNA, gene expression profiling by RT-PCR of 12 genes (8 content and 4 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence risk score


name: mRNA gene expression analysis of 12 genes in breast tumor tissue


name: Oncology (prostate), mRNA, microarray gene expression profiling of 22 content genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as metastasis risk score


name: mRNA gene expression analysis of 22 genes in prostate tumor tissue


name: mRNA gene expression analysis of 15 genes in eye melanoma o tissue or fine needle aspirate


name: Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma genitalium, amplified probe technique


name: Detection of Mycoplasma genitalium by DNA or RNA probe


name: Detection of Mycoplasma genitalium by amplified DNA probe technique


name: Detection of Mycoplasma genitalium by amplified RNA probe technique


name: IgG and IgM analysis of 80 biomarkers of systemic lupus erythematosus in serum


name: IgG and IgM analysis of 80 biomarkers for systemic lupus erythematosus in serum, algorithm reported with a risk score


name: Testing for amines associated with autism spectrum disorder in plasma


name: Protein expression profiling of 4 biomarkers of breast cancer in precancerous breast tissue


name: Protein expression profiling of 4 biomarkers for breast cancer (matrix metalloproteinase-1 [MMP-1], carcinoembryonic antigen-related cell adhesion molecule 6 [CEACAM6], hyaluronoglucosaminidase [HYAL1], highly expressed in cancer protein [HEC1]), formalin-fixed paraffin-embedded precancerous breast tissue, algorithm reported as carcinoma risk score


name: Detection of Candida species by amplified probe


name: Detection of Candida albicans, Candida glabrata, Candida parapsilosis, Candida kruseii, Candida tropicalis, and Candida auris using amplified probe technique with qualitative report of the presence or absence of each species


name: mRNA expression profiling of miR-31-3 in colon tumor tissue


name: Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) for common and select rare variants


name: Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) full sequence analysis


name: Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) full gene sequence analysis


name: Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for CYP2D6-2D7 hybrid gene


name: Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for CYP2D6-2D6 hybrid gene


name: Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for non-duplicated gene when duplication/multiplication is trans


name: Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for 5 gene duplication/multiplication


name: Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) 3' gene duplication/multiplication analysis of targeted sequence


name: Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for 3 gene duplication/multiplication


name: Detection of Immunoglobulin paraprotein (M-protein) in blood or urine


name: Detection of immunoglobulin paraprotein (M-protein), including isotype, by immunoprecipitation and mass spectrometry in blood


name: Detection of immunoglobulin paraprotein (M-protein), including isotype, by immunoprecipitation and mass spectrometry in urine


name: Gene analysis of 16 genes to evaluate risk of opioid-use disorder


name: DNA analysis of urine and cheek swabs for specimen identity verification


name: Comparative DNA analysis using multiple selected single-nucleotide polymorphisms (SNPs), in urine and buccal swab, for specimen identity verification


name: Analysis of galectin-3-binding protein and scavenger receptor cysteine-rich type 1 protein M130 in plasma, with clinical risk factors, to evaluate probability of lung cancer


name: Definitive drug testing for 90 or more drugs in urine


name: Evaluation of response to chemotherapy drugs using motility contrast tomography of fresh or frozen tissue


name: Evaluation of response to chemotherapy drugs using motility contrast tomography of fresh tissue, reported as likelihood of sensitivity or resistance


name: Evaluation of response to chemotherapy drugs using motility contrast tomography of frozen tissue, reported as likelihood of sensitivity or resistance


name: Red blood cell antigen typing, DNA, genotyping of 10 blood groups with phenotype prediction of 37 red blood cell antigens


name: Red blood cell (RBC) antigen DNA genotyping of 10 blood groups with phenotype prediction of 37 red blood cell antigens


name: Cytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA)


name: Evaluation of biomarker antibodies for inflammatory bowel disease


name: Enzyme-linked immunosorbent assay (ELISA) for cytolethal distending toxin B (CdtB) and vinculin IgG antibodies


name: Immunoassay for cytolethal distending toxin B (CdtB) and vinculin IgG antibodies


name: Infectious disease (bacterial and fungal), organism identification, blood culture, using rRNA FISH, 6 or more organism targets, reported as positive or negative with phenotypic minimum inhibitory concentration (MIC)-based antimicrobial susceptibility


name: FISH identification of organisms in blood culture


name: Identification of bacteria and fungi in blood culture by rRNA fluorescence in situ hybridization (FISH), 6 or more organism targets, reported as positive or negative with phenotypic minimum inhibitory concentration (MIC)-based antimicrobial susceptibility


name: Cardiology (heart transplant), mRNA gene expression profiling by microarray of 1283 genes, transplant biopsy tissue, allograft rejection and injury algorithm reported as a probability score


name: mRNA gene expression profiling of genes in heart transplant biopsy tissue to evaluate risk of rejection


name: mRNA gene expression profiling by microarray of 1283 genes in heart transplant biopsy tissue, algorithm reported as probability score for allograft rejection and injury


name: Transplantation medicine (kidney allograft rejection), microarray gene expression profiling of 1494 genes, utilizing transplant biopsy tissue, algorithm reported as a probability score for rejection


name: mRNA gene expression profiling of genes in kidney transplant tissue to evaluate risk of rejection


name: Microarray gene expression profiling of 1494 genes in allograft kidney transplant biopsy tissue, algorithm reported as a probability score for rejection


name: Oncology (melanoma), gene expression profiling by RTqPCR, PRAME and LINC00518, superficial collection using adhesive patch(es)


name: Gene expression profiling of melanoma in superficial sample collected by adhesive patch


name: Oncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 23 genes (14 content and 9 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical result (ie, benign, intermediate, malignant)


name: mRNA gene expression profiling of 23 genes in skin melanoma tissue sample


name: Oncology (colorectal) screening, cell enumeration of circulating tumor cells, utilizing whole blood, algorithm, for the presence of adenoma or cancer, reported as a positive or negative result


name: Colorectal cancer screening by enumeration of tumor cells in blood


name: Oncology (lung), three protein biomarkers, immunoassay using magnetic nanosensor technology, plasma, algorithm reported as risk score for likelihood of malignancy


name: Measurement of 3 protein biomarkers for lung cancer in plasma


name: Immunoassay of 3 protein biomarkers for lung cancer in plasma using magnetic nanosensor technology, algorithm reported as risk score for likelihood of malignancy


name: Prescription drug monitoring, evaluation of 65 common drugs by LC-MS/MS, urine, each drug reported detected or not detected


name: Prescription drug monitoring for 65 common drugs in urine


name: Genome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis


name: Rapid sequence analysis of genome for unexplained constitutional disorder


name: Rapid sequence analysis of genome for unexplained heritable disorder


name: Eosinophilic esophagitis (Eotaxin-3 [CCL26 {C-C motif chemokine ligand 26}] and major basic protein [PRG2 {proteoglycan 2, pro eosinophil major basic protein}]), enzyme-linked immunosorbent assays (ELISA), specimen obtained by esophageal string test device, algorithm reported as probability of active or inactive eosinophilic esophagitis


name: Test for markers of eosinophilic inflammation of esophagus


name: Test for detection of high-risk human papillomavirus in male urine


name: Detection of human papillomavirus (HPV), high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) in male urine


name: Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (15 genes [sequencing and deletion/duplication], EPCAM and GREM1 [deletion/duplication only])


name: Gene sequence analysis panel of 15 genes associated with hereditary colon cancer and related disorders


name: Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (17 genes [sequencing and deletion/duplication])


name: Gene sequence analysis panel of 17 genes associated with hereditary breast cancer and related disorders


name: Hereditary ovarian cancer (eg, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (24 genes [sequencing and deletion/duplication], EPCAM [deletion/duplication only])


name: Gene sequence analysis panel of 24 genes associated with hereditary ovarian cancer and related disorders


name: Nephrology (chronic kidney disease), multiplex electrochemiluminescent immunoassay (ECLIA) of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidney injury molecule-1 (KIM-1) combined with longitudinal clinical data, including APOL1 genotype if available, and plasma (isolated fresh or frozen), algorithm reported as probability score for rapid kidney function decline (RKFD)


name: Measurement of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidney injury molecule-1 (KIM-1) in plasma to evaluate risk of rapid kidney function decline


name: Gastric emptying, serial collection of 7 timed breath specimens, non-radioisotope carbon-13 (13C) spirulina substrate, analysis of each specimen by gas isotope ratio mass spectrometry, reported as rate of 13CO2 excretion


name: Clostridium difficile toxin(s) antigen detection by immunoassay technique, stool, qualitative, multiple-step method


name: Antigen test for detection of Clostridium difficile toxin in stool


name: Gastroenterology (Barrett's esophagus), whole slide-digital imaging, including morphometric analysis, computer-assisted quantitative immunolabeling of 9 protein biomarkers (p16, AMACR, p53, CD68, COX-2, CD45RO, HIF1a, HER-2, K20) and morphology, formalin-fixed paraffin-embedded tissue, algorithm reported as risk of progression to high-grade dysplasia or cancer


name: Computer-assisted digital imaging of esophagus specimen slides to evaluate risk of cancer


name: Infectious disease (Aspergillus species), real-time PCR for detection of DNA from 4 species (A. fumigatus, A. terreus, A. niger, and A. flavus), blood, lavage fluid, or tissue, qualitative reporting of presence or absence of each species


name: DNA test for detection of 4 Aspergillus species


name: Prescription drug monitoring, one or more oral oncology drug(s) and substances, definitive tandem mass spectrometry with chromatography, serum or plasma from capillary blood or venous blood, quantitative report with steady-state range for the prescribed drug(s) when detected


name: Monitoring of anti-cancer drugs in patient blood, serum, or plasma


name: Oncology (colon cancer), targeted KRAS (codons 12, 13, and 61) and NRAS (codons 12, 13, and 61) gene analysis, utilizing formalin-fixed paraffin-embedded tissue


name: Gene analysis (KRAS and NRAS) in prostate tumor tissue


name: Infectious agent detection and identification, targeted sequence analysis (16S and 18S rRNA genes) with drug-resistance gene


name: Gene analysis for detection of infectious agent and drug resistance gene


name: Oncology (prostate), measurement of PCA3 and TMPRSS2-ERG in urine and PSA in serum following prostatic massage, by RNA amplification and fluorescence-based detection, algorithm reported as risk score


name: Measurement of PCA3 gene in urine and prostate-specific antigen (PSA) in serum to evaluate risk of prostate cancer


name: Measurement of PCA3 and TMPRSS2-ERG in urine and PSA in serum following prostatic massage, by RNA amplification and fluorescence-based detection, algorithm reported as risk score


name: Gastroenterology (Barrett's esophagus), VIM and CCNA1 methylation analysis, esophageal cells, algorithm reported as likelihood for Barrett's esophagus


name: Gene analysis (VIM and CCNA1 methylation) in esophageal cells to evaluate likelihood of precancerous changes


name: Vimentin (VIM) and Cyclin A1 (CCNA1) methylation analysis of esophageal cells, algorithm reported as likelihood for Barrett's esophagus


name: Respiratory infectious agent detection by nucleic acid (DNA and RNA), 18 viral types and subtypes and 2 bacterial targets, amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected


name: Respiratory infectious agent detection by nucleic acid (DNA and RNA), 18 viral types and subtypes and 2 bacterial targets


name: Detection of respiratory infectious agent by nucleic acid (DNA and RNA), 18 viral types and subtypes and 2 bacterial targets, amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected


name: Prescription drug monitoring, enzyme immunoassay of 35 or more drugs confirmed with LC-MS/MS, oral fluid, algorithm results reported as a patient-compliance measurement with risk of drug to drug interactions for prescribed medications


name: Analysis of 35 or more drugs in mouth fluid to evaluate risk of prescription drug interactions


name: Pain management, analysis of 11 endogenous analytes (methylmalonic acid, xanthurenic acid, homocysteine, pyroglutamic acid, vanilmandelate, 5-hydroxyindoleacetic acid, hydroxymethylglutarate, ethylmalonate, 3-hydroxypropyl mercapturic acid (3-HPMA), quinolinic acid, kynurenic acid), LC-MS/MS, urine, algorithm reported as a pain-index score with likelihood of atypical biochemical function associated with pain


name: Analysis of 11 biochemical substances in urine to evaluate likelihood of atypical biochemical function associated with pain


name: Transplantation medicine, quantification of donor-derived cell-free DNA using whole genome next-generation sequencing, plasma, reported as percentage of donor-derived cell-free DNA in the total cell-free DNA


name: Measurement of transplant donor cell-free DNA in transplant recipient plasma


name: Quantification of transplant donor-derived cell-free DNA using whole genome next-generation sequencing, plasma, reported as percentage of donor-derived cell-free DNA in total cell-free DNA


name: Cardiology, ceramides by liquid chromatography-tandem mass spectrometry, plasma, quantitative report with risk score for major cardiovascular events


name: Measurement of ceramides for assessment of heart disease risk


name: Oncology (B-cell lymphoma classification), mRNA, gene expression profiling by fluorescent probe hybridization of 58 genes (45 content and 13 housekeeping genes), formalin-fixed paraffin-embedded tissue, algorithm reported as likelihood for primary mediastinal B-cell lymphoma (PMBCL) and diffuse large B-cell lymphoma (DLBCL) with cell of origin subtyping in the latter


name: mRNA, gene expression profiling of 58 genes in tissue sample for B-cell lymphoma classification


name: B-cell lymphoma classification, mRNA gene expression profiling by fluorescent probe hybridization of 58 genes (45 content and 13 housekeeping genes) in formalin-fixed paraffin-embedded tissue, algorithm reported as likelihood for primary mediastinal B-cell lymphoma (PMBCL) and diffuse large B-cell lymphoma (DLBCL) with cell of origin subtyping in the latter


name: Sickle cell disease, microfluidic flow adhesion (VCAM-1), whole blood


name: Blood test for sickle cells using VCAM-1


name: Sickle cell disease, microfluidic flow adhesion (P-Selectin), whole blood


name: Blood test for sickle cells using P-Selectin


name: P-Selectin microfluidic flow adhesion test in whole blood for sickle cell disease


name: Mechanical fragility, RBC, shear stress and spectral analysis profiling


name: Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis and deletion/duplication analysis panel (ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, and TP53)


name: Gene analysis of genes associated with hereditary breast cancer and related disorders for gene sequence and duplication or deletion variants


name: Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), targeted mRNA sequence analysis panel (APC, CDH1, CHEK2, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, and TP53) (List separately in addition to code for primary procedure)


name: Targeted mRNA sequence analysis of genes associated with hereditary colon cancer and related disorders


name: Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), targeted mRNA sequence analysis panel (13 genes) (List separately in addition to code for primary procedure)


name: Targeted mRNA sequence analysis of 13 genes associated with hereditary breast cancer and related disorders


name: Hereditary breast cancer-related disorders targeted mRNA sequence analysis panel including 13 genes


name: Hereditary ovarian cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), targeted mRNA sequence analysis panel (17 genes) (List separately in addition to code for primary procedure)


name: Targeted mRNA sequence analysis of 17 genes associated with hereditary ovarian cancer and related disorders


name: Hereditary prostate cancer-related disorders, targeted mRNA sequence analysis panel (11 genes) (List separately in addition to code for primary procedure)


name: Targeted mRNA sequence analysis of 11 genes associated with hereditary prostate cancer and related disorders


name: Hereditary pan cancer (eg, hereditary breast and ovarian cancer, hereditary endometrial cancer, hereditary colorectal cancer), targeted mRNA sequence analysis panel (18 genes) (List separately in addition to code for primary procedure)


name: Targeted mRNA sequence analysis of 18 genes associated with hereditary pan cancer


name: Hereditary gynecological cancer (eg, hereditary breast and ovarian cancer, hereditary endometrial cancer, hereditary colorectal cancer), targeted mRNA sequence analysis panel (12 genes) (List separately in addition to code for primary procedure)


name: Targeted mRNA sequence analysis of 12 genes associated with hereditary gynecological cancer


name: ATM (ataxia telangiectasia mutated) (eg, ataxia telangiectasia) mRNA sequence analysis (List separately in addition to code for primary procedure)


name: mRNA gene analysis (ataxia telangiectasia mutated)


name: Ataxia telangiectasia mutated (ATM) mRNA sequence analysis


name: PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) mRNA sequence analysis (List separately in addition to code for primary procedure)


name: mRNA gene analysis (partner and localizer of BRCA2)


name: BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) mRNA sequence analysis (List separately in addition to code for primary procedure)


name: mRNA gene analysis (BRCA1, DNA repair associated and BRCA2, DNA repair associated)


name: Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MenACWY-TT), for intramuscular use


name: Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use


name: Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed


name: Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; initial 15 minutes of one-on-one physician or other qualified health care professional contact with the patient


name: Biofeedback training for bowel or bladder control, initial 15 minutes


name: Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; each additional 15 minutes of one-on-one physician or other qualified health care professional contact with the patient (List separately in addition to code for primary procedure)


name: Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral


name: Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report


name: Bilateral extended ophthalmoscopy with drawing of retina and depression of sclera for evaluation of peripheral retina, with interpretation and report


name: Unilateral extended ophthalmoscopy with drawing of retina and depression of sclera for evaluation of peripheral retina, with interpretation and report


name: Ophthalmoscopy, extended; with drawing of optic nerve or macula (eg, for glaucoma, macular pathology, tumor) with interpretation and report, unilateral or bilateral


name: Bilateral extended ophthalmoscopy with drawing of optic macula, with interpretation and report


name: Unilateral extended ophthalmoscopy with drawing of macula, with interpretation and report


name: Unilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report


name: Computerized dynamic posturography sensory organization test (CDP-SOT), 6 conditions (ie, eyes open, eyes closed, visual sway, platform sway, eyes closed platform sway, platform and visual sway), including interpretation and report; with motor control test (MCT) and adaptation test (ADT)


name: Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s)


name: Evaluation of auditory function for surgically implanted device candidacy, first hour


name: Myocardial strain imaging using speckle tracking-derived assessment of myocardial mechanics (List separately in addition to codes for echocardiography imaging)


name: Myocardial strain imaging using speckle tracking-derived assessment of myocardial mechanics


name: Ambulatory blood pressure monitoring, utilizing report-generating software, automated, worn continuously for 24 hours or longer


name: Ambulatory blood pressure monitoring, utilizing report-generating software, automated, worn continuously for 24 hours or longer; recording only


name: Recording only of ambulatory blood pressure monitoring for 24 hours or longer


name: Ambulatory blood pressure monitoring, utilizing report-generating software, automated, worn continuously for 24 hours or longer; scanning analysis with report


name: Ambulatory blood pressure monitoring, utilizing report-generating software, automated, worn continuously for 24 hours or longer; review with interpretation and report


name: Review of ambulatory blood pressure monitoring for 24 hours or longer, with interpretation and report


name: Duplex scan of arterial inflow and venous outflow for preoperative vessel assessment prior to creation of hemodialysis access


name: Duplex scan of arterial inflow and venous outflow for preoperative vessel assessment prior to creation of hemodialysis access; complete bilateral study


name: Duplex scan of arterial inflow and venous outflow for preoperative vessel assessment prior to creation of hemodialysis access; complete unilateral study


name: Electroencephalogram (EEG) continuous recording, with video when performed, setup, patient education, and takedown when performed, administered in person by EEG technologist, minimum of 8 channels


name: Electroencephalogram (EEG), without video, review of data, technical description by EEG technologist, 2-12 hours


name: Electroencephalogram (EEG), without video, review of data, technical description by EEG technologist, 2-12 hours; unmonitored


name: Electroencephalogram (EEG), without video, review of data, technical description by EEG technologist, 2-12 hours; with intermittent monitoring and maintenance


name: Electroencephalogram (EEG), without video, review of data, technical description by EEG technologist, 2-12 hours; with continuous, real-time monitoring and maintenance


name: Electroencephalogram (EEG), without video, review of data, technical description by EEG technologist, each increment of 12-26 hours


name: Electroencephalogram (EEG), without video, review of data, technical description by EEG technologist, each increment of 12-26 hours; unmonitored